Vivo Capital, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Vivo Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$61.35 - $90.47 $4.15 Million - $6.12 Million	-67,680 Reduced 33.0%	137,411 $9.11 Million
Q4 2020 Feb 16, 2021	SELL	$43.82 - $85.37 $16.3 Million - $31.7 Million	-371,414 Reduced 64.43%	205,091 $15.7 Million
Q2 2020 Aug 14, 2020	SELL	$26.12 - $43.27 $5.02 Million - $8.32 Million	-192,169 Reduced 25.0%	576,505 $24.9 Million
Q1 2020 May 15, 2020	BUY	$20.56 - $63.12 $15.8 Million - $48.5 Million	768,674 New	768,674 $22.1 Million
Q3 2019 Nov 13, 2019	SELL	$26.26 - $34.86 $72.6 Million - $96.4 Million	-2,765,153 Closed	0 $0

Q2 2019 Aug 13, 2019	BUY	$17.43 - $28.82 $7.61 Million - $12.6 Million	436,678 Added 18.75%	2,765,153 $73.3 Million
Q3 2018 Nov 13, 2018	BUY	$14.0 - $20.3 $6 Million - $8.7 Million	428,475 Added 22.55%	2,328,475 $44.6 Million
Q1 2018 May 15, 2018	BUY	$3.72 - $7.64 $7.07 Million - $14.5 Million	1,900,000 New	1,900,000 $13.7 Million

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.